Patients with newly diagnosed multiple myeloma and chromosome 1 amplification have poor outcomes despite the use of novel triplet regimens.
about
Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance.Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma.Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.
P2860
Q37327618-D55FCE08-3A76-4187-983F-85C6432CE97AQ37452241-81927516-A6AA-4909-A470-716C1B2F3BA6Q38711185-F1C955D6-F122-4F2B-A4F4-3B97FA20F667Q40381229-82B47A94-0AAA-407F-9D5A-81B3BF49C9E2Q40384505-304185B0-A0FB-49CE-8D34-B1817551D943Q47562624-248EE58B-8D9F-45F1-A333-DCAAEA1B76ABQ52958429-AC1EAF75-CFAC-4FDE-8FC2-28BE87299BF0
P2860
Patients with newly diagnosed multiple myeloma and chromosome 1 amplification have poor outcomes despite the use of novel triplet regimens.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Patients with newly diagnosed ...... use of novel triplet regimens.
@en
Patients with newly diagnosed ...... use of novel triplet regimens.
@nl
type
label
Patients with newly diagnosed ...... use of novel triplet regimens.
@en
Patients with newly diagnosed ...... use of novel triplet regimens.
@nl
prefLabel
Patients with newly diagnosed ...... use of novel triplet regimens.
@en
Patients with newly diagnosed ...... use of novel triplet regimens.
@nl
P2093
P2860
P356
P1476
Patients with newly diagnosed ...... use of novel triplet regimens.
@en
P2093
Ajai Chari
Emilia Bagiella
Hearn Jay Cho
Jyoti Malhotra
Sundar Jagannath
P2860
P304
P356
10.1002/AJH.23705
P577
2014-04-30T00:00:00Z